NL-OMON55622已完成不适用
A SYSTEMS BIOLOGY APPROACH TO OCULAR INFLAMMATION - Systems biology in ocular inflammation
niversitair Medisch Centrum Utrecht0 个研究点目标入组 630 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 630
研究概览
简要总结
Trial ended prematurely
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 0 至 99（—）
入选标准
- •Patients aged under 96 years old diagnosed with ocular inflammation:
- •- uveitis; anterior uveitis, intermediate uveitis, panuveitis, scleritis and
- •posterior uveitis
- •- inflammatory corneal disease (keratokonus or Fuchs endothelial corneal
- •- inflammatory orbital disease and orbital lymphoma
- •- Age-related macular degeneration
- •- Retinal dystrophy
- •- Multifocal choroidal retinitis
- •- Strabismus
排除标准
- •- Patients with acquired immune deficiencies will not be eligible for
- •participation.
- •- Patients who do not speak or understand the Dutch language adequately will
- •also be excluded from participation in this study
- •- Current effective use of systemic immunomodulatory agents (antimetabolites),
- •biologicals or cyclosporine.
- •-IV corticosteroids in the last 14 days for inclusion
- •-Age >=96 years
研究者
相似试验
尚未招募
不适用
A systems biology approach to ocular inflammatioNL-OMON22439niversity Medical Centre Utrecht440
已完成
1 期
ANTI-TAC THERAPY FOR UVEITISUveitisNCT00001526National Eye Institute (NEI)15
撤回
3 期
Phase 3b Study for Management of Ocular Side Effects in Subjects with EGFR-Amplified Glioblastoma Receiving Depatuxizumab Mafodotin (ABT-414)GlioblastomaNL-OMON48749AbbVie Deutschland GmbH & Co. KG9
已完成
不适用
Eye and Diabetic DiseaseCTRI/2012/01/002317VPrasad Eye Institute200
已完成
2 期
Neuroprotection With Phenytoin in Optic NeuritisMultiple SclerosisOptic NeuritisNCT01451593University College, London92